Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (31 ops.)
Latest filing published 22 Dec 2023 for RAPT Therapeutics, Inc., €50k. Read the official filing
Filing timeline
BuySaleWilliam Ho
Insider track record
Disclosed buys
0
Disclosed sells
31
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
William Ho: trading record in brief
William Ho (senior executive) discloses dealings in RAPT Therapeutics, Inc. to SEC (Form 4). We count 46 filings; the first trade dates from 3 May 2021 and the latest from 21 December 2023.
The open-market record consists of 31 sales worth €1.9M, with no purchase. Besides market trades, the filings include 15 option exercises. In 2023 alone, the filings show no purchases and 8 sales.
The newest entry dates from 22 December 2023: an open-market sale of €50k, in RAPT Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William Ho
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
2,500 shares@ US$21.681.8% of flowCommon StockSEC:0001593968-23-001523:0
1,500 shares@ US$13.720.7% of flowCommon StockSEC:0001593968-23-001469:0
2,500 shares@ US$15.771.4% of flowCommon StockSEC:0001593968-23-001365:0
2,500 shares@ US$18.921.6% of flowCommon StockSEC:0001593968-23-001247:0
460 shares@ US$12.000.2% of flowCommon StockSEC:0001593968-23-001141:0
920 shares@ US$12.000.4% of flowCommon StockSEC:0001593968-23-001051:0
5,000 shares@ US$18.883.2% of flowCommon StockSEC:0001593968-23-000633:0
460 shares@ US$12.000.2% of flowCommon StockSEC:0001593968-23-000603:0
5,000 shares@ US$29.625.1% of flowCommon StockSEC:0001593968-23-000471:0
460 shares@ US$12.000.2% of flowCommon StockSEC:0001593968-23-000420:0
5,000 shares@ US$30.005.1% of flowCommon StockSEC:0001593968-23-000208:0
5,000 shares@ US$25.564.3% of flowCommon StockSEC:0001593968-23-000183:0
1,042 shares@ US$6.300.2% of flowCommon StockSEC:0001593968-23-000155:0
5,000 shares@ US$18.033.1% of flowCommon StockSEC:0001593968-22-001767:0
5,000 shares@ US$17.873.2% of flowCommon StockSEC:0001593968-22-001645:0
5,000 shares@ US$22.324.1% of flowCommon StockSEC:0001593968-22-001571:0
2,000 shares@ US$21.521.6% of flowCommon StockSEC:0001593968-22-001524:0
347 shares@ US$6.300.1% of flowCommon StockSEC:0001593968-22-001484:0
348 shares@ US$6.300.1% of flowCommon StockSEC:0001593968-22-001410:0
2,500 shares@ US$28.132.6% of flowCommon StockSEC:0001593968-22-001392:0
347 shares@ US$6.300.1% of flowCommon StockSEC:0001593968-22-001339:0
2,000 shares@ US$19.951.5% of flowCommon StockSEC:0001593968-22-001243:0
920 shares@ US$12.000.6% of flowCommon StockSEC:0001593968-22-000857:0
3,000 shares@ US$22.963.9% of flowCommon StockSEC:0001593968-22-000845:0
695 shares@ US$6.300.2% of flowCommon StockSEC:0001593968-22-000827:0
25 of 46 declarations
